Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome (PCOS) is a major health issue for women in Egypt, affecting 14% of fertile women and 37.5% of infertile women.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Isotretinoin may cause temporary, reversible facial hair growth in some women.

Lifestyle changes like diet and exercise are key for treating overweight women with polycystic ovary syndrome.

Alopecia patients have higher heart disease risk; statins and finasteride may help.

A mother's PPARγ is crucial for preventing harmful milk that can cause inflammation and growth problems in babies.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Finasteride reduces hair growth and is safe for women with excessive hair.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Lovastatin doesn't improve lower urinary tract symptoms treatment.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Lactoferrin helps mice grow hair by increasing cell growth and hair follicle development.

Premature hair graying may be a sign of increased risk for heart disease, indicating biological age is more important than actual age.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

Balding men have higher heart disease risk.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Scale created to measure hair loss in men and women; MK-386 reduces acne; Niaspan treats dyslipidemia; minoxidil increases heart rate.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Minoxidil given intravenously caused small changes in diastolic blood pressure and increased heart rate at higher concentrations in patients with high blood pressure.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

Hidden fungal infections might cause heart disease and clogged arteries.

Women with aging signs and heart issues have higher hair loss risk, which may predict shorter lifespan and affect attractiveness.

Phytotherapeutic compounds and supplements can help manage Polycystic Ovarian Syndrome (PCOS).

Metformin may help regulate periods and cause modest weight loss in PCOS patients, but more research is needed.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Iron and zinc deficiencies may be treated to help female hair loss.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.